The New Zealand sharemarket perked up after news that Australian inflation is falling faster than most commentators expected.

An uncertain New Zealand sharemarket gave up all the gains made the day before, with heavyweight Fisher and Paykel Healthcare leading the way down.

The New Zealand sharemarket began the week with a rise of more than half a percent, with the gains widely spread across the main board amongst the big and small-cap stocks.

The New Zealand sharemarket finished one of the quietest weeks of the year with another flat trading day, while some of the steam came out of United States stocks.

The New Zealand sharemarket continued a steady-as-she-goes course on quiet trading, while a buoyant Wall Street is having a jolly good time.

The New Zealand sharemarket made a small gain on further evidence that inflation is falling, but investors are wary that another official cash rate rise is on the cards by the end of the year.

The New Zealand sharemarket drifted sideways in a quiet day’s trading, while small-cap stock Metro Performance Glass rejected a takeover bid by two prominent businessmen.

The New Zealand sharemarket dipped more than half a percent as interest rate-sensitive energy stocks took a hit ahead of this week’s latest inflation data.

The New Zealand sharemarket moved into the Matariki holiday with a near one percent gain on confidence that inflation is being tamed and bond yields have peaked.

The New Zealand sharemarket had a muted response to the hold on the official cash rate, while technology company Eroad rejected a takeover offer. 

The New Zealand sharemarket lacked direction ahead of the Reserve Bank’s latest monetary review while shares bounced back offshore.

The New Zealand sharemarket gave up all the strong gains made last week as it became preoccupied with the latest inflation moves here and overseas.

The New Zealand sharemarket showed resilience in the face of increased wholesale interest rates and a big fall in shares across the Tasman.

Pacific Edge made a rapid recovery, rising more than 110% after receiving a reprieve on funding for its Cxbladder tests in the United States, while an uncertain New Zealand sharemarket had its first fall in eight trading days.

The New Zealand sharemarket picked up steam late in the day and pushed through the 12,000 points mark for the first time in seven weeks.

The sharemarkets on both sides of the Tasman enjoyed another strong day after the Reserve Bank of Australia put a hold on interest rate rises.